JP2021533201A5 - - Google Patents
Info
- Publication number
- JP2021533201A5 JP2021533201A5 JP2021529491A JP2021529491A JP2021533201A5 JP 2021533201 A5 JP2021533201 A5 JP 2021533201A5 JP 2021529491 A JP2021529491 A JP 2021529491A JP 2021529491 A JP2021529491 A JP 2021529491A JP 2021533201 A5 JP2021533201 A5 JP 2021533201A5
- Authority
- JP
- Japan
- Prior art keywords
- peg
- tent
- modified
- pharmaceutical composition
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023196375A JP7786745B2 (ja) | 2018-07-31 | 2023-11-20 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| JP2025203043A JP2026026159A (ja) | 2018-07-31 | 2025-11-25 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018902779A AU2018902779A0 (en) | 2018-07-31 | Composition and method | |
| AU2018902779 | 2018-07-31 | ||
| PCT/AU2019/050793 WO2020024002A1 (en) | 2018-07-31 | 2019-07-30 | Pegylated tetanus neurotoxins and treatment of hypotonia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023196375A Division JP7786745B2 (ja) | 2018-07-31 | 2023-11-20 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021533201A JP2021533201A (ja) | 2021-12-02 |
| JP2021533201A5 true JP2021533201A5 (https=) | 2022-08-05 |
Family
ID=69230503
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021529491A Pending JP2021533201A (ja) | 2018-07-31 | 2019-07-30 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| JP2023196375A Active JP7786745B2 (ja) | 2018-07-31 | 2023-11-20 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| JP2025203043A Pending JP2026026159A (ja) | 2018-07-31 | 2025-11-25 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023196375A Active JP7786745B2 (ja) | 2018-07-31 | 2023-11-20 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| JP2025203043A Pending JP2026026159A (ja) | 2018-07-31 | 2025-11-25 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210353724A1 (https=) |
| EP (2) | EP3830110A4 (https=) |
| JP (3) | JP2021533201A (https=) |
| KR (1) | KR20210040407A (https=) |
| CN (2) | CN120661638A (https=) |
| AU (1) | AU2019315327B2 (https=) |
| BR (1) | BR112021001520A2 (https=) |
| CA (2) | CA3108079C (https=) |
| MX (1) | MX2021001181A (https=) |
| NZ (1) | NZ772266A (https=) |
| SG (1) | SG11202100646SA (https=) |
| WO (1) | WO2020024002A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240268895A1 (en) | 2023-02-15 | 2024-08-15 | Canon Medical Systems Corporation | X-ray diagnostic apparatus, x-ray diagnostic system, and x-ray diagnostic method |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003200441B2 (en) * | 1998-04-29 | 2006-07-06 | Allergan, Inc. | Compositions and methods for modulating neural sprouting |
| GB9914861D0 (en) * | 1999-06-25 | 1999-08-25 | Imperial College | Tetanus toxin polypeptides |
| AU2001270219A1 (en) * | 2000-06-28 | 2002-01-08 | Ira Sanders | Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| WO2003000193A2 (en) * | 2001-06-21 | 2003-01-03 | Surromed, Inc. | Covalent coupling of botulinum toxin with polyethylene glycol |
| EP1531859A4 (en) * | 2002-05-31 | 2005-12-07 | Univ Jefferson | COMPOSITIONS AND METHODS FOR TRANSEPITHELIAL MOLECULAR TRANSPORT |
| WO2008024879A1 (en) * | 2006-08-25 | 2008-02-28 | University Of Maryland, Baltimore | Use of tetanus toxin to amplify inadequate voluntary muscle contraction or to improve muscle tone in an animal actively vaccinated against the toxin and a regimen for treatment |
| EP2425251B1 (en) * | 2009-04-27 | 2017-10-25 | Merz Pharma GmbH & Co. KGaA | Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities |
| LT2547364T (lt) * | 2010-03-15 | 2017-03-27 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Peptidai, konjugatai ir vakcinos imunogeniškumo padidinimo būdas |
| WO2016001762A1 (en) | 2014-07-02 | 2016-01-07 | Spherium Biomed S.L. | Methods of increasing muscle mass using non-toxic tetanus toxin c fragment (ttc) |
| BR112018003782A2 (pt) * | 2015-08-27 | 2018-09-25 | Ipsen Pharma Sas | composições e métodos para o tratamento da dor |
| CN106692963B (zh) * | 2016-12-28 | 2020-12-22 | 中国人民解放军军事医学科学院生物工程研究所 | 一种用于预防金黄色葡萄球菌感染和破伤风的联合疫苗 |
| EP3723784A4 (en) * | 2017-12-15 | 2022-01-12 | The Medical College of Wisconsin, Inc. | USE OF MODIFIED CLOSTRIDIAL NEUROTOXINS AS VACCINES AND CONJUGATE VACCINE PLATFORMS |
| JP2023513895A (ja) * | 2020-02-03 | 2023-04-04 | スノーレトックス リミテッド | 組成物及び方法 |
-
2019
- 2019-07-30 WO PCT/AU2019/050793 patent/WO2020024002A1/en not_active Ceased
- 2019-07-30 CN CN202510841942.0A patent/CN120661638A/zh active Pending
- 2019-07-30 BR BR112021001520-5A patent/BR112021001520A2/pt unknown
- 2019-07-30 AU AU2019315327A patent/AU2019315327B2/en active Active
- 2019-07-30 MX MX2021001181A patent/MX2021001181A/es unknown
- 2019-07-30 JP JP2021529491A patent/JP2021533201A/ja active Pending
- 2019-07-30 CA CA3108079A patent/CA3108079C/en active Active
- 2019-07-30 SG SG11202100646SA patent/SG11202100646SA/en unknown
- 2019-07-30 EP EP19843147.0A patent/EP3830110A4/en active Pending
- 2019-07-30 US US17/261,975 patent/US20210353724A1/en active Pending
- 2019-07-30 EP EP22183027.6A patent/EP4134133A1/en active Pending
- 2019-07-30 CA CA3167665A patent/CA3167665A1/en active Pending
- 2019-07-30 NZ NZ772266A patent/NZ772266A/en unknown
- 2019-07-30 CN CN201980057158.3A patent/CN112638937B/zh active Active
- 2019-07-30 KR KR1020217006098A patent/KR20210040407A/ko not_active Ceased
-
2023
- 2023-11-20 JP JP2023196375A patent/JP7786745B2/ja active Active
-
2025
- 2025-11-25 JP JP2025203043A patent/JP2026026159A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2471867C2 (ru) | Гиалуронидаза и способ ее применения | |
| US20250066416A1 (en) | Optimised compounds | |
| ES2979287T3 (es) | Tratamiento de infección respiratoria | |
| JP2005523946A5 (https=) | ||
| EP2277505A3 (en) | Mucoactive agents for treating a pulmonary disease | |
| RU2018138195A (ru) | Соединения 3,5-диамино-6-хлор-n-(n-(4- фенилбутил)карбамимидоил)пиразин-2-карбоксамида | |
| JP2003507438A5 (https=) | ||
| JP2020512363A5 (https=) | ||
| US20230331792A1 (en) | New multi-functional oligopeptides | |
| JP2026067913A (ja) | 新規なペプチドと多糖類とのコンジュゲート | |
| JP2024517143A5 (https=) | ||
| TW202110461A (zh) | 流行性感冒病毒感染症或冠狀病毒感染症之預防及/或治療劑 | |
| JP2016537432A5 (https=) | ||
| JP2023521623A (ja) | 過炎症性症候群の処置 | |
| JP2024511369A (ja) | 新規のペプチドコンジュゲート | |
| JP2008500277A5 (https=) | ||
| JP2021533201A5 (https=) | ||
| US20210177795A1 (en) | Administering compounds | |
| CN116568309B (zh) | 一种用于预防或治疗慢性乙型肝炎的药物组合制剂及其用途以及组合制剂试剂盒 | |
| JP6559898B2 (ja) | スクアレンを含む両親媒性ポリアミノ酸高分子に基づくワクチンの免疫補助剤組成物 | |
| JP2004529158A5 (https=) | ||
| JPWO2020255574A5 (https=) | ||
| US20210087232A1 (en) | D-enantiomeric peptides for anti-inflammatory treatment of amyotropic lateral sclerosis (als) and other diseases driven by neuro-inflammation | |
| JP2024546803A5 (https=) | ||
| US20240423933A1 (en) | Drugs for treating neurodevelopmental disorders |